A new drug targeting rogue DNA fragments driving cancer growth shows promise in treating aggressive cases. The drug aims to destroy cells containing extrachromosomal DNA (ecDNA) found in hard-to-treat cancers, preventing rapid resistance to treatment.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing